severe forms
Showing 1 - 25 of >10,000
Biomarkers Predictive of Severe Forms of COVID-19
Recruiting
- Covid19
- ELISPOT
- QUANTIFERON
-
Saint-Étienne, FranceCHU Saint-Etienne
Mar 10, 2022
Diagnostics and Pharmacotherapy for Severe Forms of TB
Completed
- Tuberculosis
- (no location specified)
Mar 8, 2022
Respiratory Eicosanoids in Prognosis of Severe Forms of Covid-19
Recruiting
- Coronavirus
- Covid19
-
Paris, FranceGroupe Hospitalier Paris Saint-Joseph
Jan 28, 2022
Pathogens Involved in Secondary Infections During Severe Forms
Recruiting
- Covid19
- +2 more
-
Paris, FranceGroupe Hospitalier Paris Saint-Joseph
Dec 29, 2021
Caused by Biomarkers in Severe Forms of COVID-19 Pneumonia
Terminated
- Community-acquired Pneumonia
- Covid19
- Blood samples
-
Paris, Ile De France, France
- +1 more
Dec 30, 2021
Children, Adult, Spastic Cerebral Palsy, Quality of Life Trial in Ljubljana (Lab tests, ECG, Cannabinoid Levels)
Recruiting
- Children, Adult
- +4 more
- Lab tests
- +8 more
-
Ljubljana, Slovenia
- +1 more
Mar 23, 2022
A Real-World Study of Anti-SARS-CoV-2 Monoclonal Antibodies
Recruiting
- Immunocompromised Patients
- Data collection
-
Paris, Ile De France, FranceAssistance Publique - Hôpitaux de Paris (AP-HP) - Cochin Hospita
Jul 5, 2022
Factors Associated With Occurrence of Severe Forms of COVID-19
Not yet recruiting
- SARS-CoV2 Infection
- +3 more
- no intervention
-
Le Kremlin-Bicêtre, FranceBicêtre Hospital
Aug 27, 2021
Covid19 Trial in Ribeirão Preto, Santo André (Ixekizumab, Aldesleukin, Colchicine)
Completed
- Covid19
- Ixekizumab
- +3 more
-
Ribeirão Preto, SP, Brazil
- +1 more
Jul 26, 2022
Gale, Severe Forms of Scabies, Oral Parasitic Drug Trial in Creteil (Ivermectin 200 µg/kg, Ivermectin 400 µg/kg)
Recruiting
- Gale
- +3 more
- Ivermectin 200 µg/kg
- Ivermectin 400 µg/kg
-
Creteil, FranceHenri Mondor Hospital
Dec 6, 2021
Composite Prognostic Score to Predict Severe Forms of Ischemic
Completed
- Ischemic Colitis
-
Montpellier, FranceUhmontpellier
Dec 3, 2020
Sickle Cell Disease Trial in Assiut (Hydroxycarbamide 500 Mg Oral Capsule+L-Carnitine, Hydroxycarbamide 500 Mg Oral Capsule,
Completed
- Sickle Cell Disease
- Hydroxycarbamide 500 Mg Oral Capsule+L-Carnitine
- +2 more
-
Assiut, EgyptSafaa A A Khaled
Oct 15, 2021
Genetic Predisposition to Severe Forms of COVID-19
Recruiting
- Covid19
- GENETIC
-
Lyon, FranceUniversity Hospital LYON (Hospices Civils de LYON)
Nov 24, 2020
Critical Forms of CoVid-19 in Chronic Respiratory Disease
Completed
- COVID
- no intervention
-
Vandoeuvre Les Nancy, FranceValentin Simon
Nov 19, 2020
COVID-19 Trial in Puebla (Convalescent plasma)
Unknown status
- COVID-19
- Convalescent plasma
-
Puebla, MexicoCentro de Hematología y Medicina Interna
Apr 21, 2020
Covid-19 and Diabetes in West of Algeria
Unknown status
- Coronavirus Infections
- +5 more
- MANAGEMENT OF COVID-19
-
Tlemcen, AlgeriaDepartment of Internal Medicine, Acedemic Hospital of Tlemcen
Jun 1, 2020
Severe Forms of Mucous Membrane Pemphigoid Trial in France (Rituximab 1g IV, Cyclophosphamide 50Mg Oral Tablet, Placebo of
Recruiting
- Severe Forms of Mucous Membrane Pemphigoid
- Rituximab 1g IV
- +3 more
-
Amiens, France
- +26 more
Oct 23, 2019
Patterns of Hemophilia Care in Assiut Children Patients
Not yet recruiting
- Hemophilia A
- Hemophilia B
- (no location specified)
Jul 29, 2023
Relation Between NAFLD and BM DENSITY
Not yet recruiting
- NAFLD
- Osteoporosis
- Fibroscan
- (no location specified)
Sep 14, 2023
Genetic Research of Monogenic Obesity inPediatric Cohort With
Not yet recruiting
- Monogenic Obesity
- Non Syndromic Obesity
- monogenic obesity
-
Bordeaux, FranceCentre Hospitalier Universitaire de Bordeaux
Oct 27, 2023
Characterisation of Adult-Onset Hypophosphatasia
Unknown status
- Hypophosphatasia
- no intervention - observational study
-
Oxford, United Kingdom
- +1 more
Jun 8, 2022
National Study on Listeriosis and Listeria
Recruiting
- Listeriosis
- +5 more
-
Paris, FranceCentre National de Reference et Centre Collaborateur OMS Listeri
Feb 2, 2023
Genetic Basis of Immunodeficiency
Recruiting
- Severe Combined Immunodeficiency
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 21, 2023
Atopic Dermatitis Trial in Roma (Upadacitinib)
Recruiting
- Atopic Dermatitis
- Upadacitinib
-
Roma, ItalyIrccs Fondazione Policlinico Gemelli
Aug 4, 2023
International (EXACOS International)
Completed
- Chronic Obstructive Pulmonary Disease
-
Santiago, Chile
- +20 more
Jan 2, 2023